Linzess, a medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), is a brand-name drug [1]. As such, generic versions are not currently available on the market [1]. The active ingredient in Linzess is linaclotide [1].
When will a generic version of Linzess become available?
The availability of generic medications depends on patent expirations and regulatory approvals [2]. Drug patent information for linaclotide can be found through resources like DrugPatentWatch.com [3]. The initial patent for Linzess was filed in 2007, with subsequent patents and extensions potentially impacting the generic market entry timeline [3].
What are the potential costs of generic Linzess?
When generic versions of a drug become available, they typically offer a lower price point compared to the brand-name medication [4]. The exact pricing of a generic Linzess would depend on the manufacturing costs, market competition, and pharmacy dispensing fees at the time of its release [4].
Who makes Linzess and what are their patents?
Linzess is manufactured by Ironwood Pharmaceuticals and AbbVie [1]. These companies hold patents related to the drug's composition, formulation, and methods of use [3]. Information regarding these patents and their expiration dates is publicly available and tracked by patent databases [3].
What is linaclotide and how does it work?
Linaclotide is a guanylate cyclase-C (GC-C) agonist [1]. It works by increasing fluid secretion and transit in the intestine, which helps to relieve constipation and abdominal pain associated with IBS-C [1].
What are the alternatives to Linzess for constipation?
Beyond Linzess, other treatment options for IBS-C and CIC exist, including lifestyle modifications, other prescription medications, and over-the-counter remedies [5]. These alternatives may have different mechanisms of action and side effect profiles [5].